$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
FDA批准Idecabtagene Vicleucel用于复发/难治性多发性骨髓瘤
2025-10-19 11:44:20
Check Details
多发性骨髓瘤最高缓解率达73%!三联疗法显神威
2025-10-19 11:44:20
Check Details
雷利度胺2020年国内最新价格
2025-10-19 11:44:20
Check Details
雷利度胺国内上市了没呢?
2025-10-19 11:44:20
Check Details
雷利度胺治疗多发性骨髓瘤疗效怎样呢?
2025-10-19 11:44:20
Check Details
雷利度胺对多发性骨髓瘤患者有多大的效果呢?
2025-10-19 11:44:20
Check Details
雷利度胺适用于什么病症呢?
2025-10-19 11:44:20
Check Details
雷利度胺治疗多发性骨髓瘤效果好吗?
2025-10-19 11:44:20
Check Details
雷利度胺适合什么人用?
2025-10-19 11:44:20
Check Details
用雷利度胺治疗期间要注意什么?
2025-10-19 11:44:20
Check Details
雷利度胺2020年纳入医保了吗?
2025-10-19 11:44:20
Check Details
来那度胺目前已知获批适应症有哪些?
2025-10-19 11:44:20
Check Details
1
2
...
1021
1022
1023
1024
1025
1026
1027
...
4151
4152
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Oncology Immunotherapy vs Anti-Inflammatory Biologic: Dostarlimab vs Secukinumab - A Mechanism-Centered Comparison
2
Third-Generation TKI Redefining Treatment for ALK+ & ROS1+ NSCLC
3
Brigatinib Medication Case Study: Three-Year Treatment Record and Experience Sharing of ALK-Positive Lung Cancer Patient
4
What is Brigatinib (Alunbrig)? Complete Guide to ALK-Positive Lung Cancer Targeted Therapy & Medication Guidelines
5
Repotrectinib (Augtyro) Complete Medication Guide 2026: Import Original Drug Price, Eligible Patients & Full Usage Information
6
Ceritinib Capsule Storage Conditions & Expiration Guide: Room Temperature Storage, No Refrigeration Needed
7
Selumetinib for NF1 Treatment: Complete Guide to Targeted Therapy for Type 1 Neurofibromatosis
8
Alectinib for ALK-Positive Lung Cancer: Efficacy, Side Effects & Clinical Outlook
9
Which Generation TKI Is Repotrectinib? Professional Analysis of Next-Gen ROS1 Inhibitor Classification and Clinical Features
10
Dietary Guide During Goserelin Treatment: Scientific Nutrition Management to Alleviate Side Effects and Improve Quality of Life.
11
CYP26A1 Gene Emerges as New Target for Colorectal Cancer Treatment! Folate Metabolism Research Brings Hope for Immunotherapy.
12
Precision Breakthrough: Inavolisib Redefines Survival in PIK3CA-Mutant Breast Cancer